RxDoctor Payments Data

Dana Day

General Practice · Farmington, MONPI 1588681035

Payments from drug & device makers

$2,094in general payments, 2019–2025

Across 114 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$316
  • AbbVie$294
  • Sandoz$223
  • Amgen$146
  • Xeris Pharmaceuticals, Inc.$142
  • AstraZeneca$122
  • plus $851 from 21 others

What the payments were for

  • Food & beverage$2,07899%
  • Entertainment$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,094 in reported general payments places this provider in the 90th percentile of 1,446 general practice providers in Missouri.

See all general practice providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide134$147,645
TrulicityDulaglutide134$133,909
OtezlaApremilast12$58,974
OzempicSemaglutide50$56,992
EliquisApixaban66$47,473
XareltoRivaroxaban58$43,325
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$42,959
JardianceEmpagliflozin50$39,821
MyrbetriqMirabegron19$18,931
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen776$18,536
Breo ElliptaFluticasone/Vilanterol20$13,095
FarxigaDapagliflozin Propanediol13$11,939
Hysingla ErHydrocodone Bitartrate12$10,458
Fluticasone-SalmeterolFluticasone Propion/Salmeterol60$9,621
Lantus SolostarInsulin Glargine,hum.Rec.Anlog56$8,837

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$113$281,554268 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$98$63,18793 claims
AmgenOtezla$146$58,97412 claims
Novo NordiskOzempic$45$56,99250 claims
Johnson & JohnsonXarelto$316$43,32558 claims
AstraZenecaFarxiga, Symbicort$122$15,82328 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,446 general practice providers in Missouri.

Other general practice in Farmington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →